Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Immunogen's Busy Month, Part I
Seeking Alpha
Tuesday, December 1, 2009 - 9:45am
tags:
Immunogen, GSK, Sanofi, Roche/Genentech
Pharma industry faces rising tax burden, PwC says
Reuters
Tuesday, December 1, 2009 - 9:21am
tags:
pharma industry, taxes
Abbott's TriCor: How a Decades-Old Drug Is Still a Patented Blockbuster
WSJ Online
Tuesday, December 1, 2009 - 9:20am
tags:
TriCor, Abbott Laboratories, cholesterol
Impotence Pill Makers Fined For Price Fixing
Pharmalot
Tuesday, December 1, 2009 - 9:18am
tags:
price fixing, Switzerland, impotence, Cialis, Pfizer, Eli Lilly, Bayer, Viagra, Levitra
Pfizer, Protalix agree deal on taliglucerase
Marketwatch
Tuesday, December 1, 2009 - 9:16am
tags:
partnerships, Protalix BioTherapeutics, Pfizer, taliglucerase, Gaucher disease
Abbott & Teva: Pay-To-Delay Or Legit Settlement?
Pharmalot
Tuesday, December 1, 2009 - 9:10am
tags:
Abbott Laboratories, Teva Pharmaceuticals, generics, TriCor
WHO approves Glaxo's swine flu shot
Yahoo/AP
Tuesday, December 1, 2009 - 9:09am
tags:
WHO, GSK, swine flu, vaccines, H1N1
Generics heat up: Cipla in talks with Big Pharma; Takeda mulls M&As
In-Pharma Technologist
Tuesday, December 1, 2009 - 7:10am
tags:
Cipla, Takeda, M&A, generics
Pfizer Will Start Generic-Drug Business in Japan
Bloomberg
Tuesday, December 1, 2009 - 6:48am
tags:
generics, Pfizer, Japan
GlaxoSmithKline takes 19 percent stake in South Africa's Aspen as it continues to diversify
Yahoo/AP
Tuesday, December 1, 2009 - 6:47am
tags:
Aspen, M&A, GSK, diversification, South Africa
Celgene: New Studies Expected to Boost Sales
Seeking Alpha
Monday, November 30, 2009 - 9:38pm
tags:
drug studies, Celgene, Revlimid
Device Maker Bets $525 Million on Recycling Medical Devices
WSJ Online
Monday, November 30, 2009 - 3:46pm
tags:
medical devices, Stryker, M&A, Ascent Healthcare Solutions
FDA Offers Pfizer's HIV Drug Selzentry New Life -- For All the Good It Will Do
BNET Pharma
Monday, November 30, 2009 - 3:40pm
tags:
Pfizer, HIV, FDA, Selzentry
Johnson & Johnson: Good & Bad News
TheStreet.com
Monday, November 30, 2009 - 3:36pm
tags:
JNJ, Revlimid, HIV, FDA, Tibotec
Abbott Laboratories grants Teva rights to cholesterol drug TriCor as early as March of 2011
Yahoo/AP
Monday, November 30, 2009 - 3:35pm
tags:
TriCor, Abbott Laboratories, Teva Pharmaceuticals, patents
Supreme Court hears case on whether shareholders waited too long to sue over Vioxx losses
Yahoo/AP
Monday, November 30, 2009 - 3:34pm
tags:
Vioxx, Merck
Drugs: Cost is the highest barrier for treatments
FT.com
Monday, November 30, 2009 - 3:33pm
tags:
drug costs, Pfizer, GSK
Genentech insists it hasn't lost its R&D mojo
Fierce Biotech
Monday, November 30, 2009 - 11:08am
tags:
R&D, Genentech, Roche
Sanofi reps await layoff news today
Fierce Pharma
Monday, November 30, 2009 - 11:06am
tags:
Sanofi, layoffs, drug reps, sales reps
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
Monday, November 30, 2009 - 11:05am
tags:
Celgene, JNJ, cancer, Revlimid, Velcade

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.